Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

MDR - Comprehensive Primary Revision Stems PMCF

NCT: NCT06788717 · ENROLLING_BY_INVITATION

NCT IDNCT06788717
StatusENROLLING_BY_INVITATION
Start Date2025-06-19
SponsorZimmer Biomet (INDUSTRY)
First posted
Last updated

Brief Summary

The objective of this retrospective and prospective consecutive series PMCF (Post Market Clinical Follow Up) study is to collect long-term data confirming safety, performance and clinical benefits of the Comprehensive Primary Revision Stems (implants and instrumentation) when used for shoulder arthroplasty at 1, 3, 5, 7 and 10 years.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑